510(k) Report

510(k) · Cleared

Cleared

Genosyl MV-1000

K120216510(k) TraditionalCleared May 16, 2012113-day reviewClass II21 CFR 868.5165

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Geno, LLC · MRN Apparatus, Nitric Oxide Delivery

Cleared on May 16, 2012 as substantially equivalent to K061901 (Ino Therapeutics, 2006) after a 113-day review. Its family tree reaches back 4 generations to 2001.

Decided
May 16, 2012
Review
113 days
Class
Class II
Product code
MRN
Recalls
None
Predicates
1

Its longest line of descent runs back 4 generations to K003665 (2001). 7 ancestors in all, the oldest K000186 (2000). No later device cites it as a predicate yet.

  1. Root · 4 generations backK003665 Fadassi Medical FM-1 NO BlenderFadasis Medical, Inc. · 2001
  2. 3 generations backK011874 Fadasis Medical FM-1 NO BlenderFadasis Medical, Inc. · 2001
  3. 2 generations backK052663 Ino Therapeutics Inoblender, Model 10004Ino Therapeutics · 2005
  4. 1 generation backK061901 Ino Therapeutics Inomax DS (Delivery System), Model 10003Ino Therapeutics · 2006 · Recalled
  5. This deviceK120216 Genosyl MV-1000Geno, LLC · 2012
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−4K003665Fadassi Medical FM-1 NO BlenderFadasis Medical, Inc.2001—
−3K011874Fadasis Medical FM-1 NO BlenderFadasis Medical, Inc.2001—
−2K052663Ino Therapeutics Inoblender, Model 10004Ino Therapeutics2005—
−1K061901Ino Therapeutics Inomax DS (Delivery System), Model 10003Ino Therapeutics20063
0 (this device)K120216Genosyl MV-1000Geno, LLC2012—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
200020
200310
FIG. 1 — Lineage of K120216, 2001–2012Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in MRN? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new MRN device

  1. #1 K242374 ULSPIRA TS™ Nitric Oxide Therapy Systemscore 12.6 · 14 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K061901Ino Therapeutics Inomax DS (Delivery System), Model 10003
Summary page 1
…868.2385 Nitrogen dioxide gas analyzer Class: All are Class 2 Predicate Devices: Ikaria INOmax DS - K061901 Device Description: GeNOsyl MV-10OO Delivery System includes four components: 1. Nitric oxide administration apparatus, pri…
Ino Therapeutics20063

Also cleared against K061901: 13 other devices →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 11 years and passes through 3 companies; a new generation was cleared every 4.3 years on median.
  • 2 of the 7 ancestors have a recall of any class.
  • 13 other devices also cite its predicate K061901.

How does its category compare?

All MRN devices

MRN Apparatus, Nitric Oxide Delivery: FDA decisions, review times, recalls and adverse event reports over 20 years. 2012, this device’s year, is highlighted.

FDA decisions per year · MRN

2in 2025

2007: 22008: 22009: 12010: 22011: 22012: 32013: 22015: 12018: 12020: 32022: 12023: 42024: 22025: 2
2007high 4 (2023) · low 0 (2014)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · MRN

566in 2023

2012: 117 days median2020: 84 days median2023: 566 days median
2007high 566 (2023) · low 84 (2020)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · MRN

2in 2025

2010: 22014: 12023: 12025: 2, 2 Class I2026 (partial year): 2
2007high 2 (2010) · low 0 (2007)2026

Class I (2 since 2007) Class II/III not classified

Adverse event reports per year · MRN

155in 2025

2007: 32008: 92009: 102010: 1552011: 552012: 242013: 322014: 792015: 1562016: 942017: 1062018: 1382019: 1442020: 1992021: 2212022: 1152023: 992024: 1382025: 155
2007high 221 (2021) · low 3 (2007)2025

MAUDE reports naming product code MRN, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20072—03
20082—09
20091—010
20102—2155
20112—055
20123117024
20132—032
20140—179
20151—0156
20160—094
20170—0106
20181—0138
20190—0144
20203840199
20210—0221
20221—0115
20234566199
20242—0138
20252—2 (2)155
20260—2—

What is it indicated for?

The GeNOsyTM MV-1000 delivers nitric oxide (NO) for inhalation therapy gas into the inspiratory limb of the patient breathing circuit in a way that provides a constant concentration of nitric oxide (NO), as set by the user. It is indicated to be used with the Bio-Med Devices CV-2± ventilator. It provides continuous integrated monitoring of inspired 02, NO2 , and NO, and a comprehensive alarm system. It incorporates a battery that provides up to 1 hour of…

Read the full statement (126 words)

The GeNOsyTM MV-1000 delivers nitric oxide (NO) for inhalation therapy gas into the inspiratory limb of the patient breathing circuit in a way that provides a constant concentration of nitric oxide (NO), as set by the user.

It is indicated to be used with the Bio-Med Devices CV-2± ventilator.

It provides continuous integrated monitoring of inspired 02, NO2 , and NO, and a comprehensive alarm system.

It incorporates a battery that provides up to 1 hour of uninterrupted NO delivery in the absence of an external power source.

It includes a backup NO delivery capability that provides a fixed flow of 250 mL/min of NO which along with user supplied 10 L/min of oxygen provides 20 ppm in the gas flow to a patient's breathing circuit.,

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K120216: Genosyl MV-1000.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K120216

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026